Journal of Clinical Oncology

Reply to: Optimizing Outcomes After Transoral Robotic Surgery for Oropharyngeal Carcinoma: Reflections on the ASCO Guideline

F F. Christopher Holsinger (F. Christopher Holsinger, MD, FACS, Stanford University, Palo Alto, CA; Nofisat Ismaila, MD, MSc, American Society of Clinical Oncology (ASCO), Alexandria, VA; and Jamie A. Ku, MD, FACS, Cleveland Clinic, Cleveland, OH) N Nofisat Ismaila (American Society of Clinical Oncology (ASCO), Alexandria, VA, US) J Jamie A. Ku (F. Christopher Holsinger, MD, FACS, Stanford University, Palo Alto, CA; Nofisat Ismaila, MD, MSc, American Society of Clinical Oncology (ASCO), Alexandria, VA; and Jamie A. Ku, MD, FACS, Cleveland Clinic, Cleveland, OH)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 43, Issue 23
Published August 10, 2025
Pages 2656-2657
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (3)

F

F. Christopher Holsinger

F. Christopher Holsinger, MD, FACS, Stanford University, Palo Alto, CA; Nofisat Ismaila, MD, MSc, American Society of Clinical Oncology (ASCO), Alexandria, VA; and Jamie A. Ku, MD, FACS, Cleveland Clinic, Cleveland, OH

N

Nofisat Ismaila

American Society of Clinical Oncology (ASCO), Alexandria, VA, US

J

Jamie A. Ku

F. Christopher Holsinger, MD, FACS, Stanford University, Palo Alto, CA; Nofisat Ismaila, MD, MSc, American Society of Clinical Oncology (ASCO), Alexandria, VA; and Jamie A. Ku, MD, FACS, Cleveland Clinic, Cleveland, OH

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001